A clinical trial to evaluate efficacy of topical netarsudil in comparison to topical latanoprost in primary angle closure disease spectrum
Phase 4
- Conditions
- Health Condition 1: H402- Primary angle-closure glaucoma
- Registration Number
- CTRI/2023/02/049928
- Lead Sponsor
- Advanced Eye Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Primary angle closure spectrum of patients with Intraocular more than 21 mmHg will be randomised to receive both the drugs.
Exclusion Criteria
one eyed patient, secondary glaucomas, open angle glaucoma, previous history of angle surgeries, previous history of trabecular meshwork lasers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome: Percentage IOP reduction from baseline in both groups and its comparision at 3 monthsTimepoint: At end of 3 months the IOP reduction will be compared in form of percentage reduction
- Secondary Outcome Measures
Name Time Method Best corrected visual acuity and visual field changes at 3 monthsTimepoint: 3rd month